Bio

Bio


Dr. Hong specializes in the treatment of pediatric patients with neurosurgical conditions, with additional specialty training in the treatment of pediatric spinal disorders, including scoliosis. He completed his residency in his home state of Michigan at the Detroit Medical Center, and completed fellowship training at Rady Children's Hospital in San Diego, before becoming a part of Stanford Children's Health.

His clinical interests include brain tumors, epilepsy surgery, idiopathic scoliosis, Chiari malformation, vascular conditions, concussion, and will treat all other conditions within the specialty.

Clinical Focus


  • Neurosurgery
  • Pediatric Neurosurgery
  • Pediatric brain tumors
  • Spinal deformity
  • Adolescent scoliosis
  • Chiari malformation and syrinx
  • Tethered cord
  • Spina bifida
  • Moyamoya syndrome
  • Craniosynostosis
  • Plagiocephaly
  • Brachial plexus palsy
  • Epilepsy surgery
  • Concussion

Academic Appointments


Boards, Advisory Committees, Professional Organizations


  • Member, Council of Korean Americans (2018 - Present)
  • Member, National Committee on North Korea (2018 - Present)
  • Member, American Association of Neurological Surgeons (2008 - Present)
  • Member, Congress of Neurological Surgeons (2008 - Present)

Professional Education


  • Fellowship:University of California San Diego Medical Center (2015) CA
  • Residency:Wayne State University/ Detroit Medical Center (2014)
  • Internship:Wayne State University/ Detroit Medical Center (2008)
  • Medical Education:New York University School of Medicine (2007) NY

Community and International Work


  • KAMA Global Health Outreach Program, Pyongyang, DPRK

    Topic

    Pediatric Neurosurgery

    Partnering Organization(s)

    Korean Medical Association

    Populations Served

    children

    Location

    International

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    Yes

Publications

All Publications


  • ASL PERFUSION IMAGING OF THE FRONTAL LOBES PREDICTS THE OCCURRENCE AND RESOLUTION OF POSTERIOR FOSSA SYNDROME Yecies, D., Shpanskaya, K., Grant, G., Cheshier, S., Hong, D., Edwards, M., Yeom, K. OXFORD UNIV PRESS INC. 2018: 170
  • Near-Fatal Gastrointestinal Hemorrhage in a Child with Medulloblastoma on High Dose Dexamethasone. Cureus Yecies, D., Tawfik, D., Damman, J., Thorson, C., Hong, D. S., Grant, G. A., Bensen, R., Damian, M. 2017; 9 (7): e1442

    Abstract

    A four-year-old female was admitted to a university-based children's hospital with a newly-diagnosed posterior fossa tumor. She was started on famotidine and high-dose dexamethasone and underwent gross total resection of a medulloblastoma. She was continued on dexamethasone and famotidine. She exhibited postoperative posterior fossa syndrome and was started on enteral feeds via the nasoduodenal tube. She had small gastrointestinal bleeds on postoperative days eight, 11, and 18, and was found to have a well-circumscribed posterior duodenal ulcer. On postoperative day 19, she suffered a massive life-threatening gastrointestinal bleed requiring aggressive resuscitation with blood products. She required an emergent laparotomy due to ongoing blood loss and she was found to have posterior duodenal wall erosion into her gastroduodenal artery. She recovered and subsequently began delayed chemotherapy. This case demonstrates a rare and life-threatening complication of high-dose dexamethasone therapy in the setting of posterior fossa pathology despite stress ulcer prophylaxis. We present a historical perspective with the review of the association between duodenal and intracranial pathology and the usage of high-dose dexamethasone in such cases.

    View details for DOI 10.7759/cureus.1442

    View details for PubMedID 28924528

    View details for PubMedCentralID PMC5589501

  • Post-operative diabetes insipidus after endoscopic transsphenoidal surgery PITUITARY Schreckinger, M., Walker, B., Knepper, J., Hornyak, M., Hong, D., Kim, J., Folbe, A., Guthikonda, M., Mittal, S., Szerlip, N. J. 2013; 16 (4): 445-451

    Abstract

    Diabetes insipidus (DI) after endoscopic transsphenoidal surgery (ETSS) can lead to increased morbidity, longer hospital stays, and increased medication requirements. Predicting which patients are at high risk for developing DI can help direct services to ensure adequate care and follow-up. The objective of this study was to review our institution's experience with ETSS and determine which clinical/laboratory variables are associated with DI in this patient population. The authors wanted to see if there was an easily determined single value that would help predict which patients develop DI. This represents the largest North American series of this type. We retrospectively reviewed the charts of patients who had undergone ETSS for resection of sellar and parasellar pathology between 2006 and 2011. We examined patient and tumor characteristics and their relationship to postoperative DI. Out of 172 endoscopic transsphenoidal surgeries, there were 15 cases of transient DI (8.7%) and 14 cases of permanent DI (8.1%). Statistically significant predictors of postoperative DI (p < 0.05) included tumor volume and histopathology (Rathke's cleft cyst and craniopharyngioma). Significant indicators of development of DI were postoperative serum sodium, preoperative to postoperative change in sodium level, and urine output prior to administration of 1-deamino-8-D-arginine vasopressin. An increase in serum sodium of ≥2.5 mmol/L is a positive marker of development of DI with 80% specificity, and a postoperative serum sodium of ≥145 mmol/L is a positive indicator with 98% specificity. Identifying perioperative risk factors and objective indicators of DI after ETSS will help physicians care for patients postoperatively. In this large series, we demonstrated that there were multiple perioperative risk factors for the development of DI. These findings, which are consistent with other reports from microscopic surgical series, will help identify patients at risk for diabetes insipidus, aid in planning treatment algorithms, and increase vigilance in high risk patients.

    View details for DOI 10.1007/s11102-012-0453-1

    View details for Web of Science ID 000326891400003

    View details for PubMedID 23242859

  • Endovascular management of a giant aneurysm through saphenous vein graft after extracranial-intracranial bypass: case report and literature review JOURNAL OF NEUROINTERVENTIONAL SURGERY Pandey, P., Rayes, M., Hong, D., Guthikonda, M., Xavier, A. 2011; 3 (4): 361-363

    Abstract

    It is known that giant intracerebral aneurysms have a high rupture and mortality rate. Furthermore, their optimal treatment method is not straightforward. While traditionally they have been managed with surgical clipping, it is not always possible. A unique case is presented in which a patient with multiple intracranial aneurysms was treated using a multimodality approach. After an intracranial-extracranial bypass, the left internal carotid artery ophthalmic aneurysm continued to grow on follow-up angiogram. Thus it was decided to go ahead with coiling of the aneurysm. The coils were delivered through the saphenous vein graft. The patient tolerated the procedure well and there were no procedural complications.

    View details for DOI 10.1136/jnis.2011.004739

    View details for Web of Science ID 000296793400015

    View details for PubMedID 21990469